Genetic landscape of idiopathic pulmonary fibrosis: A systematic review, meta-analysis and epidemiological evidence of case-control studies
Pooja SinghiD, Debleena GuiniD, BIJAY RANJAN PATTNAIKiD, Ritushree KukretiiD
Abstract
BackgroundIdiopathic pulmonary fibrosis (IPF) is a fibrotic lung disorder of unknown cause, affecting about three million people worldwide. Being a multifactorial disease, complex genetic and environmental factors contribute to its susceptibility. Therefore, we conducted a two-staged systematic literature search and meta-analyses of published genetic association studies on IPF. MethodsThe first search was performed using PubMed and Web of Science, retrieving a total of 5642 articles, of which 57 publications were eligible for inclusion in the first stage. The Second search was performed using PubMed, Web of Science and Scopus for all genetic variants, identified from the first search, with 2 or more studies. Thus, six variants [rs35705950 (MUC5B), rs2736100 (TERT), rs2609255 (FAM13A), rs2076295 (DSP), rs12610495 (DPP9) and rs1800470 (TGF-{beta}1)] from this search qualified for meta-analyses. Additionally, the epidemiological credibility of these six variants was evaluated using the Venice criteria. ResultsIn this systematic review, 291 polymorphisms were found to be associated with IPF susceptibility. Meta-analyses findings revealed significant (p < 0.05) risk association of rs35705950 [T vs C; OR = 3.85(3.24-4.47)], rs2609255 [G vs T; OR = 1.37(1.27-1.47)], rs2076295 [G vs T; OR = 1.31(1.00-1.63)], rs12610495 [G vs A; OR = 1.29(1.21-1.37)] and rs1800470 [T vs C; OR = 1.08(0.82-1.34)] and protective association of rs2736100 [C vs A; OR = 0.70(0.61-0.79)] with IPF susceptibility. Cumulative epidemiological evidence was graded as strong for rs35705950, moderate for rs2736100, rs2609255 and rs12610495, and weak for rs2076295 and rs1800470. ConclusionsOur findings present the most prominent IPF-associated genetic risk variants involved in alveolar epithelial injuries (MUC5B, TERT, FAM13A, DSP, DPP9) and epithelial-mesenchymal transition (TGF-{beta}1), providing genetic and biological insights into IPF pathogenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants
Ritah Nabunje, Beatriz Guillén‐Guío, … Richard J. Allen·medRxiv·Apr 25, 2026
- Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis
Richard J. Allen, Beatriz Guillén‐Guío, … Louise V. Wain·American Journal of Respiratory and Critical Care MedicinePeer-reviewed·Nov 11, 2019
- Polygenic Risk and Rare Variants in Endotypes of Idiopathic Pulmonary Fibrosis
Anna Duckworth, Leigh M. Jackson, … David Zhang·The Lancet Respiratory MedicinePeer-reviewed·Jan 27, 2026
- Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasets
Daniel Chin, Tamara Hernández-Beeftink, … Louise V. Wain·European Respiratory JournalPeer-reviewed·May 21, 2026
- Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis
Richard J. Allen, Amy Stockwell, … Louise V. Wain·ThoraxPeer-reviewed·Jun 10, 2022
- Contribution of dominant and recessive model effects to the genetic architecture of Idiopathic Pulmonary Fibrosis
Tamara Hernández-Beeftink, Lauren J. Donoghue, … Louise V. Wain·medRxiv·Feb 19, 2026